Effect of Cytomegalovirus Reactivation on Inflammatory Status and Mortality of Older COVID-19 Patients
暂无分享,去创建一个
A. Bonfigli | M. Provinciali | M. Cardelli | F. Marchegiani | E. Pierpaoli | F. Lattanzio | A. Cherubini | R. Galeazzi | T. Casoli | R. Antonicelli | F. Marcheselli | R. Recchioni | R. Giacconi | M. di Rosa | R. Sarzani | C. di Pentima | F. Piacenza | M. Fedecostante | P. Giordano | P. Stripoli | Elisabetta Farnocchia
[1] M. Peluso,et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. , 2022, The Journal of clinical investigation.
[2] N. Rocchetti,et al. [COVID-19 and herpesvirus encephalitis]. , 2022, Revista de neurologia.
[3] A. Bonfigli,et al. Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients , 2022, Mechanisms of Ageing and Development.
[4] A. Friggeri,et al. Senior-COVID-Rea Cohort Study: A Geriatric Prediction Model of 30-day Mortality in Patients Aged over 60 Years in ICU for Severe COVID-19 , 2022, Aging and disease.
[5] M. Bonafè,et al. Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes , 2022, Mechanisms of Ageing and Development.
[6] R. Varma,et al. Clinical Profile and Determinants of Mortality in Patients With COVID-19: A Retrospective Analytical Cross-Sectional Study in a Tertiary Care Center in South India , 2022, Cureus.
[7] A. Cohen,et al. Physiological health indexes predict deterioration and mortality in patients with COVID-19: a comparative study , 2022, Aging.
[8] Y. Morinaga,et al. Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure , 2022, Frontiers in Immunology.
[9] X. Lv,et al. Emergent Virus Reactivation in SARS-CoV-2-Negative Community Acquired Pneumonia Patients During the COVID-19 Pandemic , 2022, Frontiers in Microbiology.
[10] A. AlRajhi,et al. Cytomegalovirus pneumonitis amid COVID-19 chaos: the hidden enemy—a case report , 2022, Journal of Medical Case Reports.
[11] OUP accepted manuscript , 2022, The Journal of Infectious Diseases.
[12] A. Shimabukuro-Vornhagen,et al. Reactivation of EBV and CMV in Severe COVID-19—Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients , 2021, Journal of intensive care medicine.
[13] É. Azoulay,et al. Herpesvirus reactivation during severe COVID-19 and high rate of immune defect , 2021, Infectious Diseases Now.
[14] S. Peixoto,et al. Cytomegalovirus and herpes simplex type 1 infections and immunological profile of community-dwelling older adults , 2021, Experimental Gerontology.
[15] M. Gómez-Valent,et al. [Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients]. , 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[16] A. Moreau,et al. High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19 , 2021, Infectious Diseases Now.
[17] W. Lim,et al. Predictors for development of critical illness amongst older adults with COVID-19: Beyond age to age-associated factors , 2020, Archives of Gerontology and Geriatrics.
[18] Mohammad Ali Moni,et al. Machine Learning Approaches to Identify Patient Comorbidities and Symptoms That Increased Risk of Mortality in COVID-19 , 2020, Diagnostics.
[19] Yi Jiang,et al. Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study , 2020, Scientific Reports.
[20] Anwar Abdelnaser,et al. COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence , 2020, Frontiers in Pharmacology.
[21] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[22] Joshua R. Peck,et al. Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy , 2020, IDCases.
[23] S. Roll,et al. COVID-19 and Cytomegalovirus Co-infection: A Challenging Case of a Critically Ill Patient with Gastrointestinal Symptoms. , 2020, European journal of case reports in internal medicine.
[24] J. Tadié,et al. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients , 2020, Critical Care.
[25] M. Girardis,et al. Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] Lin Wang,et al. Co‐reactivation of the human herpesvirus alpha subfamily (herpes simplex virus‐1 and varicella zoster virus) in a critically ill patient with COVID‐19 , 2020, The British journal of dermatology.
[27] E. Shin,et al. The type I interferon response in COVID-19: implications for treatment , 2020, Nature Reviews Immunology.
[28] P. Klenerman,et al. Why the elderly appear to be more severely affected by COVID‐19: The potential role of immunosenescence and CMV , 2020, Reviews in medical virology.
[29] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[30] N. Raja,et al. Presenting features of COVID-19 in older people: relationships with frailty, inflammation and mortality , 2020, European Geriatric Medicine.
[31] D. Acharya,et al. Dysregulation of type I interferon responses in COVID-19 , 2020, Nature Reviews Immunology.
[32] Z. Tian,et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[33] W. Xia,et al. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China , 2020, Journal of Infection.
[34] A. Loundou,et al. Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO , 2019, Annals of Intensive Care.
[35] I. Martín-Loeches,et al. Influenza Infections and Emergent Viral Infections in Intensive Care Unit , 2019, Seminars in Respiratory and Critical Care Medicine.
[36] J. V. van Dongen,et al. Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells , 2017, Scientific Reports.
[37] A. Souquette,et al. A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness , 2017, GeroScience.
[38] R. Featherstone,et al. Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis , 2017, Open forum infectious diseases.
[39] S. Walter,et al. T‐Cell Phenotypes Predictive of Frailty and Mortality in Elderly Nursing Home Residents , 2017, Journal of the American Geriatrics Society.
[40] T. Kirkwood,et al. CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study , 2015, Aging cell.
[41] T. van der Poll,et al. Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome , 2016, Intensive Care Medicine.
[42] T. May,et al. Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression , 2015, Journal of Virology.
[43] T. Murayama,et al. Human cytomegalovirus replication supported by virus-induced activation of CCL2-CCR2 interactions. , 2014, Biochemical and biophysical research communications.
[44] J. Margolick,et al. Chronic CMV infection in older women: Longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8+ T-cell frequencies with twelve year follow-up , 2014, Experimental Gerontology.
[45] D. Farber,et al. Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.
[46] S. Shang,et al. HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro. , 2012, Viral immunology.
[47] G. Pawelec,et al. Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly1 , 2006, The Journal of Immunology.
[48] I. McDowell,et al. A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.
[49] R. Würzner,et al. Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+ T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons , 2005, Journal of Virology.